tiprankstipranks
SynAct Pharma AB (SE:SYNACT)
:SYNACT
Sweden Market
Want to see SE:SYNACT full AI Analyst Report?

SynAct Pharma AB (SYNACT) Technical Analysis

2 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
SynAct Pharma AB’s (SYNACT) Moving Averages Convergence Divergence (MACD) indicator is -0.45, suggesting SynAct Pharma AB is a Sell.
SynAct Pharma AB’s (SYNACT) 20-Day exponential moving average is 14.59, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) 50-Day exponential moving average is 15.69, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.

SynAct Pharma AB (SYNACT) Pivot Points

Jun 14, 2026, 06:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
12.34
12.86
13.70
14.22
15.06
15.58
16.42
Fibonacci
12.86
13.38
13.70
14.22
14.74
15.06
15.58
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

SynAct Pharma AB (SYNACT) Moving Averages

Jun 14, 2026, 06:30 PM
Period
Simple
Exponential
MA5
14.18Buy
14.28Buy
MA10
14.08Buy
14.31Buy
MA20
14.47Buy
14.59Sell
MA50
15.93Sell
15.69Sell
MA100
17.64Sell
17.08Sell
MA200
19.47Sell
18.56Sell
SynAct Pharma AB’s (SYNACT) 10-Day exponential moving average is 14.31, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Buy.
SynAct Pharma AB’s (SYNACT) 100-Day exponential moving average is 17.08, while SynAct Pharma AB’s (SYNACT) share price is kr23.8, making it a Sell.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 50-day simple moving average is 15.93, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 100-day simple moving average is 17.64, creating a Sell signal.
SynAct Pharma AB’s (SYNACT) stock price is kr23.8 and SynAct Pharma AB’s (SYNACT) 200-day simple moving average is 19.47, creating a Sell signal.

SynAct Pharma AB (SYNACT) Technical Indicators

Jun 14, 2026, 06:30 PM
Name
Value
Implied Action
RSI (14)
47.78
Neutral
STOCH (9,6)
36.02
Neutral
STOCHRSI (14)
26.79
Neutral
MACD (12,26)
-0.45
Sell
ADX (14)
25.22
Neutral
Williams %R
-69.81
Buy
CCI (14)
-2.36
Neutral
ATR (14)
1.22
-
Ultimate Oscillator
49.13
Neutral
ROC
11.54
Buy
SynAct Pharma AB’s (SYNACT) Relative Strength Index (RSI) is 47.78, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Trend Strength Indicator (ADX) is 25.22, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Commodity Channel Index (CCI) is -2.36, creating a Neutral signal.
SynAct Pharma AB’s (SYNACT) Price Rate of Change (ROC) is 11.54, creating a Buy signal.

FAQ

Is SYNACT a Buy, Hold, or Sell?
Based on SYNACT’s technical indicators, SYNACT is a Hold.
    What is SYNACT’s RSI (14)?
    SYNACT’s RSI (14) is 47.78, which suggests SYNACT is a Neutral.
      What is SYNACT’s MACD?
      SYNACT’s MACD is -0.45, which suggests SYNACT is a Sell.
        What is SYNACT’s 5-day moving average?
        SYNACT’s 5-day moving average is 14.18, which suggests SYNACT is a Buy.
          What is SYNACT’s 20-day moving average?
          SYNACT 20-day moving average is 14.47, which suggests SYNACT is a Buy.
            What is SYNACT’s 50-day moving average?
            SYNACT’s 50-day moving average is 15.93, which suggests SYNACT is a Sell.
              What is SYNACT’s 200-day moving average?
              SYNACT’s 200-day moving average is 19.47, which suggests SYNACT is a Sell.
                What is SYNACT’s Williams % R (14)?
                SYNACT’s Williams % R (14) is -69.81, which suggests SYNACT is a Buy.
                  What is SYNACT’s CCI (14)?
                  SYNACT’s CCI (14) is -2.36, which suggests SYNACT is a Neutral.
                    What is the share price of SynAct Pharma AB?